98717-38-5

Upstream product

• 75738-79-3 (+)-(R)-γ-(4-fluorophenyl)-γ-butyrolactone 
• 76700-25-9 (+)-4a,9b-trans-8-fluoro-5-(4-fluorophenyl)-1,2,3,4,4a,9b-hexahydro-γ-carboline 
• 51787-96-3 5-(4-fluorophenyl)dihydrofuran-2(3H)-one 
• 87545-51-5 dl-4-hydroxy-4-(4-fluorophenyl)butyric acid 
• 75738-74-8 l-4-hydroxy-4-(4-fluorophenyl)butyric acid 
• 69623-07-0 (+/-)-4a,9b-trans-8-fluoro-5-(4-fluorophenyl)-2,3,4,4a,5,9a-hexahydro-1H-pyrido<4,3-b>indole 

Downstream Products

• 74311-69-6 (R)-4-[(4aS,9bS)-8-Fluoro-5-(4-fluoro-phenyl)-1,3,4,4a,5,9b-hexahydro-pyrido[4,3-b]indol-2-yl]-1-(4-fluoro-phenyl)-butan-1-ol 

Relevant academic research and scientific papers

Neuroleptic Activity of Chiral trans-Hexahydro-γ-carbolines

A series of trans-8-fluoro-5-(4-fluorophenyl)-2,3,4,4a,5,9b-hexahydro-1H-pyridoindoles with various N-2 substituents has been prepared and tested for neuroleptic activity (3H>spiroperidol binding and amphetamine antagonism).Several memb